Valacyclovir oral suspension (Hyloris Pharmaceuticals)

N/A

Report date: 2025/05/23 10:45:13

Base Information

Drug NameValacyclovir oral suspension (Hyloris Pharmaceuticals)
Drug Alias NameHY-029HF-029HY-REF-029
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitorsHuman herpesvirus 5 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesHyloris Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesHyloris Pharmaceuticals SAHyloris Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A